Wellgistics Health Adds Quantum Key Encryption to PharmacyChain(TM) AI-Enabled Blockchain Smart Contract Partnership with DataVault AI

Rhea-AI Summary

Wellgistics Health (NASDAQ:WGRX) announced a strategic licensing partnership with DataVault AI (NASDAQ:DVLT) to integrate quantum key encryption and DataVault's patented Information Data Exchange (IDE) into Wellgistics' blockchain smart contract platform PharmacyChain, combined with its EinsteinRx AI for pharmacy dispensing optimization.

The partners completed a feasibility assessment and set pilot milestones across 2026, targeting blockchain selection by Q1 2026, HIPAA-compliant closed-loop transfers by Q2 2026, a pilot contract close by Q3 2026, and network marketing by year-end 2026; the network covers >6,500 independent pharmacies.

Positive

• Adds quantum key encryption to protect pharmacy data against future quantum threats
• Licensing of DataVault AI's patented IDE enables tokenization of pharmacy processes
• Defined pilot timeline with milestones across Q1–Q4 2026
• Access to a network of over 6,500 independent pharmacies for pilots and rollouts

Negative

• Solution remains pre-commercial; revenue impact uncertain until pilot(s) complete by Q3 2026
• Deployment depends on selecting compatible blockchain platform by end of Q1 2026, posing timeline risk

News Market Reaction

+10.54%

5 alerts

+10.54% News Effect

+7.1% Peak in 55 min

+$3M Valuation Impact

$35M Market Cap

0.0x Rel. Volume

On the day this news was published, WGRX gained 10.54%, reflecting a significant positive market reaction. Argus tracked a peak move of +7.1% during that session. Our momentum scanner triggered 5 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $3M to the company's valuation, bringing the market cap to $35M at that time.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

U.S. prescription drug market: $634 billion U.S. prescription drug market 2030: $883 billion Blockchain in healthcare market: $11 billion +5 more

8 metrics

U.S. prescription drug market $634 billion Current market size cited for PharmacyChain opportunity

U.S. prescription drug market 2030 $883 billion Projected 2030 market size per Grandview Research

Blockchain in healthcare market $11 billion Current global blockchain in healthcare market size

Blockchain healthcare 2030 $214 billion Projected 2030 blockchain in healthcare market per Grandview Research

Wellgistics pharmacy network over 6,500 pharmacies Network size benefiting from PharmacyChain and EinsteinRx

Pilot deployment target year-end 2026 Goal to reach pilot deployment of PharmacyChain by end of 2026

Blockchain selection milestone end of Q1 2026 Deadline to select suitable blockchain platforms for initial deployment

Pilot contract milestone end of Q3 2026 Target to close a PharmacyChain Contract with an early adopter pharmacy

Market Reality Check

Price: $0.4066 Vol: Volume 448,736 is 15% abo...

normal vol

$0.4066 Last Close

Volume Volume 448,736 is 15% above the 20-day average of 391,207. normal

Technical Shares at $0.3929 are trading below the 200-day MA of $1.47, far under the $7.04 52-week high.

Peers on Argus

WGRX fell 2.51% with modestly elevated volume, while peers were mixed: SSY up 9....

WGRX fell 2.51% with modestly elevated volume, while peers were mixed: SSY up 9.31%, SCNX up 2.02%, HKPD up 0.73%, HITI down 3.27%, PETS flat. No peers appeared in the momentum scanner, pointing to a stock-specific move.

Historical Context

5 past events · Latest: Jan 07 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Jan 07	Corporate outlook	Positive	-3.5%	Outlined 2026 AI integration and pharmacy onboarding targets across its network.
Dec 17	Token record date	Positive	-7.1%	Reminded shareholders of record date for Dream Bowl 2026 meme coin tokens.
Dec 08	Drug launch	Positive	+7.7%	Announced Brenzavvy launch to 6,500+ pharmacies targeting type II diabetes market.
Dec 04	Meme coin distribution	Positive	+7.0%	Declared 1-for-1 Dream Bowl 2026 meme coin distribution to shareholders.
Nov 26	Sponsorship & tokens	Positive	+14.8%	Announced Dream Bowl 2026 sponsorship and participation in meme coin plan.

Pattern Detected

Recent WGRX news skews promotional or strategic; reactions have been mixed, with some positive commercial or promotional updates producing strong gains while other seemingly constructive updates saw negative follow-through.

Recent Company History

Over the past few months, Wellgistics has focused on building its EinsteinRx and PharmacyChain ecosystem across a network of over 6,500 independent pharmacies. It launched diabetes drug Brenzavvy into this network and highlighted meme coin distributions and Dream Bowl sponsorships tied to DataVault AI. A 2026 corporate outlook emphasized onboarding up to 500 pharmacies per month by year-end 2026. Today’s AI-enabled, quantum-encrypted PharmacyChain update builds on the November 2025 DataVault licensing agreements disclosed in multiple 8-K filings.

Market Pulse Summary

The stock surged +10.5% in the session following this news. A strong positive reaction aligns with m...

Analysis

The stock surged +10.5% in the session following this news. A strong positive reaction aligns with management’s strategy of pairing EinsteinRx with PharmacyChain to target large markets like the $634 billion U.S. prescription drug sector and the projected $214 billion blockchain-in-healthcare space. Past strategic announcements have sometimes produced sharp gains, but investors must weigh this momentum against prior regulatory disclosures, including going-concern language and Nasdaq bid-price noncompliance, which highlight execution and financing risks.

Key Terms

quantum key encryption, blockchain-enabled smart contracts, tokenization, distributed ledger technologies, +4 more

8 terms

quantum key encryption technical

"PharmacyChain™ to leverage Datavault AI's edge network and quantum key encryption..."

Quantum key encryption is a way of creating and sharing secret codes using properties of quantum physics so that any eavesdropping can be detected. Think of it as handing someone a lock-and-key made of fragile glass: if an intruder touches it, you immediately know. For investors it matters because it can make communications and financial systems far harder to hack, creating demand for new security services and affecting risk profiles for technology and data-sensitive companies.

blockchain-enabled smart contracts technical

"integrating ... EinsteinRx™ into its patented blockchain-enabled smart contracts platform..."

Blockchain-enabled smart contracts are self-executing agreements stored on a digital ledger that automatically enforce their terms when certain conditions are met. They function like digital vending machines: once the predefined rules are satisfied, the contract completes without needing a third party. For investors, these contracts can reduce costs, increase transparency, and ensure transactions happen reliably and instantly.

tokenization technical

"to integrate proprietary blockchain-enabled tokenization and blockchain-enabled smart contract capabilities..."

Tokenization is the process of converting real-world assets or rights into digital tokens stored on a computer network. This allows assets, such as property or investments, to be divided into smaller parts, making them easier to buy, sell, or transfer electronically. For investors, tokenization can increase access to a wider range of investments and make transactions faster and more efficient.

distributed ledger technologies technical

"transformative potential that distributed ledger technologies possess to improve traceability..."

Distributed ledger technologies are systems that record and share the same transaction history across many computers instead of keeping a single, central record — think of a shared spreadsheet that everyone can see and verify but no one person controls. For investors, these systems can change how value is moved, tracked and trusted by reducing middlemen, lowering costs, increasing transparency and creating new business models, while also introducing technical, regulatory and adoption risks.

Information Data Exchange technical

"including its patented Information Data Exchange® (IDE) and expertise in securely attaching..."

A structured flow of facts and figures between organizations, systems, or people that lets them share updates, reports and decisions quickly and accurately. Think of it as a common language or exchange of shared notes that reduces misunderstandings, speeds up responses and helps markets and managers react to the same information at the same time. For investors, reliable data exchange improves transparency, lowers information delays and reduces the chance of costly surprises or regulatory problems.

HIPAA-compliant regulatory

"Establish the 'closed loop' initial HIPAA-compliant data transfers required to close a..."

HIPAA-compliant means that a product, service, or organization follows the U.S. Health Insurance Portability and Accountability Act’s rules for protecting patients’ private health information, including technical controls, physical safeguards, and record-keeping. For investors, compliance matters because it reduces risks of costly fines, lawsuits and reputational damage, and it can be a requirement to sell into healthcare markets — like having a certified lockbox and an audit trail that reassures customers and regulators.

smart contract technical

"required to close a smart contract-enabled prescription drug transactions (the 'PharmacyChain Contract')..."

A smart contract is a computer program stored on a blockchain that automatically carries out the terms of an agreement when preset conditions are met — like a vending machine that releases a snack when you insert the right coins. For investors, smart contracts matter because they can cut out intermediaries, speed up and lower the cost of transactions, and make outcomes more transparent, but they also introduce technology and regulatory risks that can affect asset value.

edge network technical

"PharmacyChain™ to leverage Datavault AI's edge network and quantum key encryption..."

A network of small data centers and computing resources placed close to users and devices rather than in one central facility, so processing and storage happen near the “edge” of the internet. Investors care because edge networks reduce delays and cut bandwidth costs for cloud services, streaming, and connected devices, which can boost revenue, lower operating expenses, and enable new products—like choosing a neighborhood grocery instead of a distant supermarket for faster access.

AI-generated analysis. Not financial advice.

• Feasibility assessment completed, PharmacyChain™ to leverage Datavault AI's edge network and quantum key encryption to improve data driven outcomes in $634 billion prescription drug market

• Quantum key encryption fortities pharmacies from quantum's pending encryption-busting impact on traditional encryption methods

TAMPA, FLORIDA / ACCESS Newswire / January 12, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence ('AI') platform EinsteinRx™ into its patented blockchain-enabled smart contracts platform PharmacyChain™, today provided an update on its strategic licensing partnership with DataVault AI, Inc. (NASDAQ:DVLT), a Pioneer in AI-driven data valuation, monetization, and secure tokenization within Web 3.0 environments.

Through this partnership, Wellgistics has licensed DataVault AI's advanced technology platform to integrate proprietary blockchain-enabled tokenization and blockchain-enabled smart contract capabilities into its patented PharmacyChain™ platform. This enables tokenization of Wellgistics' AI-enabled pharmacy chain - powered by its EinsteinRx™ pharmacy dispensing optimization artificial intelligence - creating secure, immutable digital twins of real-world pharmacy processes, transactions, and assets.

The U.S. prescription drug market, where independent pharmacies play a vital role, represents a $634 billion market opportunity, projected to grow to $883 billion by 2030 according to Grandview Research. This market continues to face significant challenges, including supply chain inefficiencies, lack of transparency, fraud, waste, and delayed payments that strain pharmacy profitability and patient care. The global blockchain in healthcare market currently stands at $11 billion USD, and is projected to grow to $214 billion by 2030 according to Grandview Research, with compound annual rates expected to exceed 60% per year. The size of these two markets expected to be disrupted by EinsteinRx and PharmacyChain underscore the transformative potential that distributed ledger technologies possess to improve traceability, security, and automation in healthcare.

DataVault AI's industry-leading platform, including its patented Information Data Exchange® (IDE) and expertise in securely attaching physical assets to immutable blockchain metadata, provide the foundational intellectual property that enables this tokenization. By leveraging DataVault AI's robust, regulatory-compliant technology, Wellgistics can create tokenized digital representations of pharmacy chain elements - from prescription fulfillment to supply chain provenance - facilitating seamless smart contract execution, real-time data integrity, reduced intermediaries, and new avenues for efficient, trustless transactions across its network of over 6,500 pharmacies.

The companies have successfully completed the feasibility assessment phase and established key milestones toward pilot deployment by year-end 2026:

• Complete initial selection of which blockchain platforms are most suitable for the initial deployment of PharmacyChain by the end of the first quarter of 2026;

• Establish the 'closed loop' initial HIPAA-compliant data transfers required to close a smart contract-enabled prescription drug transactions (the 'PharmacyChain Contract') via Wellgistics' own pharmacy by the end of the second quarter of 2026;

• Successfully close a PharmacyChain Contract via a pilot program with an early adopter pharmacy from among Wellgistics' 6,500 independent pharmacy clients (the 'Wellgistics Pharmacy Network') by the end of the third quarter of 2026;

• Begin to expand marketing of PharmacyChain to the entire Wellgistics Pharmacy Network by year-end 2026.

"Partnering with DataVault AI represented a crucial step forward for Wellgistics as we prepare to deploy out technologies in our efforts to modernize the U.S. prescription drug ecosystem," said Prashant Patel, RPh, President & Interim-CEO of Wellgistics Health. "DataVault AI's technology platform is uniquely positioned to enable secure, scalable tokenization that complements our EinsteinRx AI and PharmacyChain smart contracts. This combination is being designed to deliver unprecedented transparency, efficiency, and fraud prevention to our pharmacy network - from optimized drug selection and adherence support to streamlined payments and waste elimination. We are excited about the validated strength of DataVault AI's IP and platform, which provides the critical guardrails needed in today's evolving regulatory landscape. As we progress, we anticipate meaningful enhancements in pharmacy profitability, patient safety, and overall healthcare delivery."

About Datavault AI Inc.

Datavault AI™ (Nasdaq:DVLT) is leading the way in AI driven data experiences, valuation, and monetization of assets in the Web 3.0 environment. The Company's cloud-based platform provides comprehensive solutions with a collaborative focus in its Acoustic Science and Data Science Divisions. Datavault AI's Acoustic Science Division features WiSA®, ADIO® and Sumerian® patented technologies and industry-first foundational spatial and multichannel wireless HD sound transmission technologies with IP covering audio timing, synchronization, and multi-channel interference cancellation. The Data Science Division leverages the power of Web 3.0 and high-performance computing to provide solutions for experiential data perception, valuation, and secure monetization. Datavault AI's cloud-based platform provides comprehensive solutions serving multiple industries, including HPC software licensing for sports & entertainment, events & venues, biotech, education, fintech, real estate, healthcare, energy and more. The Information Data Exchange® (IDE) enables Digital Twins, licensing of name, image, and likeness (NIL) by securely attaching physical real-world objects to immutable metadata objects, fostering responsible AI with integrity. Datavault AI's technology suite is completely customizable and offers AI and Machine Learning (ML) automation, third-party integration, detailed analytics and data, marketing automation, and advertising monitoring. The Company is headquartered in Philadelphia, PA.

Learn more about Datavault AI at www.dvlt.ai.

About Wellgistics Health, Inc.

Wellgistics Health (NASDAQ: WGRX) is a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence platform EinsteinRx™ into its patented blockchain-enabled smart contracts platform PharmacyChain™ to optimize the prescription drug dispending journey. Its integrated platform connects 6,500+ pharmacies (the "Wellgistics Pharmacy Network") and 200+ manufacturers, offering wholesale distribution, digital prescription routing, direct-to-patient delivery, and AI-powered hub services such as eligibility, adherence, onboarding, prior authorization, and cash-pay fulfillment as needed to optimize patient access. Wellgistics provides end-to-end solutions designed to restore access, transparency, and trust in the U.S. prescription drug market for independent pharmacies.

For more information, visit www.wellgisticshealth.com.

Forward-Looking Statements

This press release contains forward‑looking statements within the meaning of the federal securities laws, including, without limitation, statements regarding the parties' plans to negotiate definitive agreements, potential implementation, adoption, performance, revenue sharing, and other anticipated benefits of the contemplated collaboration. These statements are subject to risks and uncertainties that could cause actual results to differ materially, including those described in DataVault AI, Inc.'s and Wellgistics Health, Inc.'s filings with the SEC. Forward‑looking statements speak only as of the date hereof, and neither company undertakes any obligation to update them except as required by law. Additional factors are discussed in Wellgistics Health's filings with the SEC, available at www.sec.gov.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction, and there shall be no sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

DataVault AI Corporate Communications

IBN
Austin, Texas
www.InvestorBrandNetwork.com
512.354.7000 Office
Editor@InvestorBrandNetwork.com

DataVault AI Media Contact:
marketing@dvlt.ai

Wellgistics Media & Investor Contact

Media:
media@wellgisticshealth.com

Investor Relations:
IR@wellgisticshealth.com

SOURCE: Wellgistics Health, Inc.

View the original press release on ACCESS Newswire

FAQ

What did Wellgistics (WGRX) announce on January 12, 2026 about PharmacyChain?

Wellgistics announced a licensing partnership with DataVault AI to add tokenization, smart contracts, and quantum key encryption to PharmacyChain and completed a feasibility assessment.

What is the pilot timeline for PharmacyChain and WGRX in 2026?

Milestones target blockchain selection by Q1 2026, HIPAA-compliant closed-loop transfers by Q2 2026, a pilot contract close by Q3 2026, and wider marketing by year-end 2026.

How many pharmacies could be reached through Wellgistics' PharmacyChain pilot for WGRX?

The company cited a Wellgistics Pharmacy Network of over 6,500 independent pharmacies as the initial addressable network for pilots and rollout.

What does the addition of quantum key encryption mean for WGRX's PharmacyChain?

Quantum key encryption is intended to fortify data security against future quantum decryption risks and strengthen blockchain-based transaction protections.

Will the PharmacyChain integration with DataVault AI immediately drive revenue for WGRX?

No; the integration is at pilot stage and revenue impact remains uncertain until pilots close and deployments expand beyond early adopters.

Which blockchain-related step is critical for the PharmacyChain 2026 plan for WGRX?

Selecting the most suitable blockchain platform by the end of Q1 2026 is a critical step before HIPAA-compliant transfers and pilot execution.